Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211744 · ClinicalTrials.gov registry record · Phase 4
Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT00211744 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 24 participants.
The verdict
NCT00211744, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
A 12-week program to examine the effectiveness of topiramate in adjunctive treatment for adults with obsessive-compulsive disorder and who are currently on serotonin reuptake inhibitor medications (ages 18-65).
Interventions
- DRUG topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-08 |
| Est. Completion | 2006-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00211744
The ClinicalTrials.gov registry entry for NCT00211744 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which topiramate is the first listed.
NCT00211744 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00211744 about?
NCT00211744 is a clinical study titled "Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder". A 12-week program to examine the effectiveness of topiramate in adjunctive treatment for adults with obsessive-compulsive disorder and who are currently on serotonin reuptake inhibitor medications (ages 18-65).
What is the current status of trial NCT00211744?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2004-08. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00211744?
The interventions under investigation include: topiramate (DRUG).
Who is sponsoring clinical trial NCT00211744?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.